Interferon Gamma Regulation of De Novo Protein Synthesis in Human Dermal Fibroblasts in Culture Is Anatomic Site Dependent  by Smith, Terry J. & Higgins, Paul J.
Interferon Gamma Regulation of De Novo Protein 
Synthesis in Human Dermal Fibroblasts in Culture Is 
Anatomic Site Dependent 
Terry J. Smith and Paul J. Higgins 
Division of Molecular and Cellular Medicine, Department of Medicine, Department of Biochemistry and Molecular Biology, and 
Department of Microbiology and Immunology, Albany Medical College and the Veterans Affairs Medical Center, Albany, New York, 
U .S.A. 
The propensity of the skin of the lower anterior leg to be 
involved in Graves' dermopathy prompted an examination of 
the specific protein synthesis and response to interferon 
gamma in cultured fibroblasts from this area. Confluent cul-
tures from normal skin of the lower leg and from the abdo-
men of the same three donors were pulse labeled with 
[35S]methionine for 3 h and subjected to two-dimensional 
protein gel electrophoresis and fluorography. Protein spots 
were mapped using a computer-driven program and the rela-
tive densities of the resolvable spots analyzed. Fibroblasts 
from the two anatomic sites display distinct patterns of de novo 
protein synthesis. Of the 157 abundant spots arbitrarily cho-
sen for analysis, 31 % varied substantially in levels of expres-
sion between the sites. A number of proteins appear to be 
C onsiderable evidence suggests that cultured fibro-blasts eminating from different human organs be-have in specialized and perhaps unique ways. For instance, gingival fibroblasts respond to the addition of diphenylhydantoin into culture medium with an 
increased collagen synthetic rate, whereas dermal fibroblasts are 
unaffected [1]. The accumulation of glycosaminoglycan in lung and 
orbital fibroblast but not in dermal fibroblast cultures is stimulated 
by interferon gamma [2,3]. Dermal fibroblasts [4-6]' but not those 
derived from the human orbit [7], respond to 3,S,3'-L-triiodothyro-
nine and glucocorticoids in regard to hyaluronate synthesis. Even 
among dermal fibroblasts, anatomic site-specific differences in cel-
lular metabolism have been reported. For instance, genital fibro-
blasts metabolize androgens differently than do those obtained from 
deltoid or abdominal skin [8]. 
A satisfactory explanation has yet to be offered for the involve-
ment of discrete dermal regions in systemic diseases such as Graves' 
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Abbreviations: 
FBS: fetal bovine serum 
HLA-DR: human leukocyte antigen-DR 
IEP: isoelectric focusing 
PAl-I : plasminogen activator inhibitor type-l 
50S-PAGE: sodium dodecyl sulfate-polyacrylamide gel electro-
phoreSis 
expressed only in cultures derived from one of the two 
anatomic sites. Interferon gamma (100 U jml) present 
in the culture medium for 48 h influenced the abundance 
of a number of proteins in a site-specific manner. Among 
them, plasminogen activator inhibitor type-l was induced 
three to five times in the leg cultures, whereas this 
same polypeptide was down-regulated in abdominal fibro-
blasts. A 54-kD protein was induced in interferon-treated 
cultures from both sites at least 50 times. It appears that 
fibroblasts from different regions of the integument are in-
trinsically distinct in terms of both their protein synthetic 
programs and their responses to cytokines. ] Invest Dermatol 
100:288-292,1993 
disease, in which an autoimmune hyperplastic goiter is in some cases 
associated with ophthalmopathy and dermopathy [9]. The dermo-
pathic process is usually confined to the skin of the anterior shin [9]. 
Pretibial fibroblasts, but not those from the prepuce or the skin of 
the back, respond to sera of patients with dermopathy associated 
with Graves' disease [10]. Those sera may contain a protease-sensi-
tive, heat-stable, dialyzable factor distinct from 7 S gamma globulin 
that could stimulate hyaluronate accumulation selectively in the 
pretibial fibroblasts. Thus, there is reason to believe that pretibial 
fibroblasts may differ from those eminating from other regions of 
the integument. 
In this paper, we describe studies involving the two-dimensional 
gel electrophoretic analysis of cell-layer-associated fibroblast pro-
teins from dermal cultures of pretibial and abdominal origin. The 
results suggest that the protein synthetic programs in fibroblasts 
from the two distant anatomic regions are distinct. Moreover, inter-
feron gamma influences the synthesis of specific proteins in these 
fibroblast strains in a site-dependent manner. 
MATERIALS AND METHODS 
Cell Culture Primary fibroblast cultures derived from normal 
tissue of individuals with Graves' disease or those without thyroid 
dysfunction were initiated from dermal biopsies as described previ-
ously [11]. The Albany Medical College Institutional Review Board 
approval has been obtained for these activities. Monolayers were 
allowed to proliferate to a state of confluence in 3S-mm diameter 
plastic culture plates covered with Eagle's medium containing 10% 
fetal bovine serum (FBS), glutamine, and antibiotics. Cultures were 
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Table I. Protein Synthesis in Cultured Human Dermal 
Fibroblasts Derived from the Leg and Abdomen 
Culture Conditions' 
Control 
INF-gamma 
Acid-Insoluble cpm (X lO- S)' 
(calf) 
74.6 ± 9.7' 
67.0 ± 11.5 
(abdomen) 
73.9 ± 12.1 
66.0 ± 11 .5 
• Cells were grown to confluence then exposed to nothing (control) or interferon-
gamma (INF-gamma; 100 U/rnl) for an adclitional2 d . 
• Cultures were labeled for 3 h in FBS-/ methionine-free meclium containing 
[3SS)-methionine as described under Materials .tld Methods. Cells were lysed in first-
climension buffer and TCA-insoluble raclioactivity determined by 6.ltration . 
, Mean ± standard deviation. 
maintained in a humidifed, 5% CO2 incubator at a constant tempera-
ture of 37 0 C. The experiments used fibroblasts of a similar passage 
number, which was always less than 15. Some cultures were treated 
with interferon gamma for 48 h. The growth media were removed, 
and labeling medium containing FBS, methionine-free RPM! 1640 
medium, and [35S]methionine, specific activity> 1100 Cijmmol 
(50,uCi/ml) (New England Nuclear, Boston, MA) without (con-
trol) or with the cytokine was added. Metabolic labeling proceeded 
for 3 h. 
Two-dimensional Protein Gel Electrophoresis Labeling 
media were collected and clarified by centrifugation at 13,000 X g. 
Cell lysates were prepared in first-dimensional buffer (9.8 M urea, 
2% Nonidet P-40, 2% pH 7.9 ampholytes, 100 mMdithiothreitol). 
[35S]methionine-Iabeled cellular proteins (5 X 105 to 2 X 106 cpm) 
were separated by isoelectric focusing (IEF) on pre-run 1.5 mm 
diameter tube gels (pH 5-7/3-10 ampholytes, 5 : I, v Iv) before mo-
kDa 
97-
68-
43-
29-
IEF~ 
abdomenllNF 
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lecular mass separation by 10% sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE). Labeled proteins 
were detected by f1uorography and quantitated densitometrically 
with a Bioimage gel scanner (Milligen Corp) interfaced with a 
SUN SPARC work station or with a Zeiss MOPS III image analyzer 
[12]. Proteins were identified according to their pI/M r coordinates 
using the REF52 data base [13]. Each datum point included in 
Tables II, III, and IV represents the mean ± SD of density analysis 
in triplicate of protein spots of three gels, each derived from a 
different donor 's culture strain. 
RESULTS 
Comparison of Specific Protein Synthesis in Cultured Leg 
and AbdOlninal Dermal Fibroblasts Cultured human dermal 
fibroblasts actively incorporate [3SS]methionine into many discrete 
proteins, several hundred of which are sufficiently abundant to be 
resolved on two-dimensional protein gel electrophoretic f1uoro-
grams. Although the various strains did not differ in regard to the 
uptake of radio labeled amino acid precursor or its conversion to 
acid-insoluble material (Table I), the pattern of de /lOVO protein 
synthesis in pretibial skin fibroblasts varied substantially from cul-
tures of abdominal skin (Fig 1). The data contained in Table II are 
from an analysis of the protein gels depicted in Fig 1 and strains 
from two additional donors. When 157 arbitrarily chosen spots 
were quantitated densitometrically and compared, a number were 
more or less abundant, depending on the anatomic source. Of these 
spots, 106 were expressed equally in leg and abdominal fibroblasts . 
The data from 35 representative spots are presented in Table II. 
Proteins expressed at invariant levels in leg and abdominal cultures 
include fibronectin (spot 1), collagen (spot 2) , vimentin (spot 91), 
and actin (spot 114). Of the remaining spots, 24 proteins expressed 
in the leg varied from - 93% to +sixfold with respect to their 
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Figure 1. Two-dimensional gel electrophoresis of [3SS]methionine-labeled proteins from human fibroblasts in culture. Confiuent cultures from abdomi-
nal and pretibial skin were treated for 2 d without (control) or with human recombinant interferon gamma (IFN; 100 U / mJ) and then labeled for the final 
3 h. Samples were prepared as described in Materials atld Methods. Gels (10% polyacrylamide) were then dried and subjected to autofluorography for 1 
week at -70 ' C followed by scanning densitometry. The large circles surround protein spots used to standardize the scanning procedure. Brackets, vimentin 
degradation products. Spot numbering was arbitrary. 
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Table II. Quantitation of the Relative Abundance of 35 
Major Proteins Expressed by Human Dermal Fibroblasts· 
Relative Abundance 
X100 b 
Spot pl/M, Tentative (OD leg/OD abdomen, 
Number Coorctina tes Identification in percent) 
1 6.7/220 Fibronectin 110.9 ± 12.6' 
2 6.8/190 Collagen 90.3 ± 13.1 
6 4.9/230 Unidentified 364.7 ± 42.4 
10 5.6/130 Unidentified 104.0 ± 8.0 
11 5.4/130 Unidentified 146.3 ± 31.2 
16 6.8/107 Unidentified 355.0 ± 66.6 
18 6.3/100 Unidentified s5 
19 6.2/100 Unidentified s5 
20 5.6/100 Unidentified 88.3 ± 9.7 
27 5.4/94 Alpha-actin 91.4 ± 7.6 
34 7.0/93 Unidentified 19.2 ± 10.2 
37 6.2/92 Unidentified 75 .9 ± 11 .8 
39 6.5/91 Unidentified 117.4 ± 22.3 
42 5.6/87 Unidentified 18.1 ± 6.5 
43 5.5/86 Unidentified S5 
47 8.0/90 Unidentified 77.7 ± 9.2 
51 5.6/78 Unidentified S5 
59 6.2/70 Unidentified S5 
91 5.1/57 Vimentin 94.4 ± 18.3 
97 7.0/57 Unidentified 198.3 ± 72.1 
98 7.3/56 Unidentified 576.5 ± 109.6 
99 7.5/55 Unidentified 420.7 ± 99 .9 
107 6.2/46 PAl-l 212.0 ± 51.0 
108 6.1/46 PAl-l 144.3 ± 32.5 
109 5.9/46 PAl-1 91.1 ± 21.7 
109a 5.8/46 PAl-1 230.4 ± 19.6 
109b 5.7/46 PAl-l 100.1 ± 11.5 
109c 5.6/46 PAl-1 80.7 ± 10.3 
110 4.9/55 . Vimentin ll1.8 ± 16.4 
degradation 
113 4.9/41 Tropomyosin 30.3 ± 15.6 
114 5.2/43 Actin 102.8 ± 11.0 
115 4.8/37 Tropomyosin 11.7 ± 5.3 
116 4.9/35 TM-asso- 109.8 ± 17.2 
ciated 
119 5.0/30 TM-asso- 157.4 ± 38.1 
ciated 
149 5.9/54 In terferon- Not detected 
gamma in-
ducible 
protein 
• Derived from the leg and abdomen of three donors. 
• 00, optical density. 
, Mean ± standard deviation. 
counterparts in abdominal cultures. The plasminogen activator in-
hibitor type-I (PAl-I) isoforms (spots 107, 108, 109, 109a, 109b, 
109c) are expressed at equivalent levels with the exception of 
spots 107 and t09a, which are twofold higher in the leg strains. 
The identity of these spots has been confirmed previously in both 
rodent kidney [14] and human orbital fibroblasts [12]. Differences 
in the charge characteristics displayed by the various PAI-l iso-
forms are thought to be a consequence of a heterogeneous sialation 
pattern [12]. The remaining 25 abundant proteins analyzed in ab-
dominal cultures were either absent or expressed at extremely low 
levels ($ 5%) in the leg cultures. Abdominal strains may possess 
a more diverse protein synthetic repertoire when compared with 
the leg cells. Alternatively, match-point analysis simply may have 
fail ed to detect a number of protein counterparts in the leg cul-
tures. 
Anatomic Site-Dependent Differences in Interferon Gam-
ma Induction of Protein Synthesis in Dermal Fibroblasts 
Interferon gamma treatment alters the synthetic rates of several 
abundant proteins expressed in dermal fibroblast cultures and resol-
vable on two-dimensional protein gel electrophoresis. As Fig 1 and 
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Table Ill. Effects of Interferon Gamma on Specific Protein 
Synthesis in Dermal Fibroblasts from the Leg of Three Donors 
Relative Abundance X 100 
Spot Number (OD Interferon/OD control, in percent)· 
1 
2 
6 
10 
II 
16 
18 
19 
20 
27 
34 
37 
39 
42 
43 
47 
51 
59 
91 
97 
98 
99 
107 
108 
109 
109a 
109b 
109c 
110 
113 
114 
115 
116 
119 
149 
• 00, optical density. 
• Mean ± standard deviation. 
, Based on data from two strains. 
67.8 ± 13 .4b 
11.8 ± 4.6' 
426.0 ± 96.0 
27.0 ± 13.1 
10.2 ± 3.2 
99.3 ± 13.9 
Not detected 
Not detected 
2l.3 ± 16.5 
30.4 ± 14.7 
266.3 ± 63.1 
339.9 ± 63.7' 
102.5 ± 18.3 
220.1 ± 23.2 
Not detected 
187.2 ± 45.5 
Not detected 
Not detected 
113.7 ± 24.2 
434.6 ± 107.1 
47.9 ± 10.3 
33.5 ± 10.9 
344.2 ± 93.7 
506.2 ± 197.3 
499.1 ± 158.2 
386.0 ± 149.9 
390.7 ± 63.3 
305.5 ± 97.8 
42 .8 ± 16.7 
206.7 ± 25 .4 
102.6 ± 7.6 
36.3 ± 8.3' 
79 .3 ± 10.1 
90.6 ± 10.8 
>50 times 
the data in Tables III and IV suggest, the cytokine can up- or down-
regulate specific protein synthesis in fibroblast cultures, depending 
on the anatomic region of derivation. In dermal cultures derived 
from leg, only 14% of the 129 protein spots suitable for densitome-
tric analysis changed substantially with interferon gamma treat-
ment. of those 129 spots, 35 representative proteins are included in 
the tables. Spots 107 -109c, the PAI-l isoforms, were induced from 
three to five and a half times above control levels. Spot 149, repre-
senting the 54 kD (pI-5.9) interferon-dependent protein [15] was 
induced greater than 50 times (relative to background levels) in both 
leg and abdominal cultures but was undetectable in cultures not 
receiving the cytokine. Spot 6 (M, 230, pI 4.9) was induced (four-
fold) in the leg cultures as were spots 37 (3.4 times), 97 (4.3 times), 
and 47 (1. 9 times). In contrast, spot 2 (M, 190, pI 6.8), a collagen, 
was down-regulated dramatically to 12% of the level seen in con-
trols. Synthetic rates of spots 10, 11, and 20 were also inhibited 
70 -90%. 
Many of the same proteins appeared to be influenced by inter-
feron gamma in both leg and abdominal skin fibroblasts. For in-
stance, collagen (spot 2) is inhibited in strains from both anatomic 
sites, more or less equivalently. Spots 37 and 47 are induced equiva-
lently as is the 54-kD interferon-dependent protein (spot 149). 
However, striking differences in the response to interferon gamma 
were also noted. The PAI-l isoforms in the abdominal strains were 
down-regulated 45% to 94% below control levels, compared with 
the marked up-regulation in the leg cultures. Likewise, spot 97 was 
down-regulated twofold in the abdomen, in contrast to the substan-
tial induction in leg fibroblasts. 
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Table IV. Effects of Interferon Gamma on Specific Protein 
Synthesis in Dermal Fibroblasts from the Abdomen of 3 Donors 
Spot Number 
1 
2 
6 
10 
11 
16 
18 
19 
20 
27 
34 
37 
39 
42 
43 
47 
51 
59 
91 
97 
98 
99 
107 
108 
109 
109a 
109b 
109c 
110 
113 
114 
115 
116 
119 
149 
• 00, optical density. 
• Mean ± standard deviation. 
, Based on data from two strains. 
Relative Abundance X 100 
(OD Interferon/OD control, in percent)' 
41.7 ± 12.9b 
:=;5 
97.6 ± 8.3 
98.4 ± 19.2 
60.5 ± 20.1' 
367.6 ± 51.5 
363.8 ± 99.6 
24.3 ± 15.9 
239.0 ± 38.5 
104.4 ± 20.3' 
48.8 ± 18.6 
387.2 ± 91.5 
>6 times 
108.3 ± 19.7 
105.1 ± 10.4 
383.7 ± 62.8 
296.2 ± 90.5 
90.2 ± 15.6 
107.5 ± 16.1 
33.4 ± 11.7 
29 .0 ± 8.8 
43 .7 ± 20.1 
66.1 ± 19.9 
39.5 ± 18.7 
Not detected 
25 .1 ± 3.3' 
50.5 ± 10.6 
:=;5 
56.3 ± 31.8 
507.5 ± 153.6 
102.3 ± 14.1 
59.5 ± 20.2 
91.7 ± 10.3 
92.4 ± 8.9' 
> 50 times 
DISCUSSION 
Differences in the pattern of specific protein synthesis found in 
fibroblasts from distant anatomic regions of the integument may 
explain the distribution of cutaneous manifestations characteristic 
of certain systemic diseases. In these studies, we examined the re-
sponse to interferon gamma of fibroblasts from the skin of the 
anterior shin as representative of those cells activated in the context 
of Graves' dermopathy. When compared with abdominal skin fibro-
blasts, those from the leg demonstrated a substantial induction of 
PAl-I , whereas abdominal PAI-l expression was down-regulated to 
levels below detectability. The 54-kD protein (pi 5.9) known to be 
inducible in most interferon gamma responsive cell types [15] was 
induced in cells from both sites equally. 
The differential response of PAI-l to interferon gamma may have 
implications in the context of inflammatory processes involving the 
skin. Because that polypeptide is an important determinant of the 
pericellular proteolytic environment [16]. the up-regulation in the 
leg-derived fibroblast strains may increase matrix stability and thus 
favor accumulation of extracellular proteins. Those proteins and 
hyaluronate appear to be important components of the poorly char-
acterized amorphous material accumulating in pre-tibial myxedema 
lesions [17, 18J. We have already proposed that the profound in-
duction by interferon gamma of PAI-l in orbital fibroblast cultures 
[12] coupled with the apparently site-specific stimulation of glycosa-
minoglycan accumulation in those cultures [3] may be relevant to 
the pathogenesis of Graves' ophthalmopathy. 
The studies reported here involved fibroblasts derived from two 
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sites in each of three donors. In all instances, interferon gamma 
induced PAI-l synthesis substantially in the leg fibroblasts, whereas 
expression of the polypeptide in abdominal cultures was decreased 
by the cytokine. It is as yet unclear whether the up-regulation of 
PAI-l in leg cultures seen here will be universal for all strains ob-
tained from the shin. Moreover, it is uncertain whether the down-
regulation observed in the abdominal fibroblast strains is character-
istic of all cultures obtained from the torso. Many more strains from 
these and other anatomic sites will need to be examined before any 
such conclusions can be made. What does emerge from these results 
is that, within an individual donor, PAI-1 expression and regulation 
by. cytokines in dermal fibrobl as ts varies from one anatomic site to 
another. 
Interferon gamma can alter the transcriptional rates of specific 
genes in a variety of cell types [19]. Many of the nuclear actions of 
this cytokine are thought to be mediated through its binding to a 
~embrane-bound receptor [20] and the activation of the protein 
kinase C cascade [21]. Proteins whose synthetic rates are altered in 
response to interferon gamma include that encoded by the class II 
major histocompatibility gene human leukocyte antigen DR 
(HLA-DR) [21,22]. The expression of HLA-DR is ordinarily lim-
ited to lymphoid tissues; however, many cell types synthesize this 
antigen-presenting protein when exposed to interferon gamma. 
We have reported that fibroblasts of dermal and orbital connective 
tissue origin respond to the cytokine in this manner and that the 
induction can be modulated by other cytokines [23] and glucocorti-
coids [24]. In the current studies, we do not demonstrate a promi-
nent interferon-inducible protein that would correspond to HLA-
DR at 63 kD. This is likely the consequence of the relative short 
treatment periods used in this study (48 h) as compared to those 
necessary to detect immunoquantifiable HLA-DR antigen in stud-
ies using these fibroblasts (96-120 h) [23]. 
There is reason to suspect that interferon gamma may be a patho-
genic factor in Graves' disease. HLA-DR is aberrantly expressed in 
thyrocytes of involved glands [25,26] . Moreover, the antigen has 
been demonstrated in the orbital connective tissue from a patient 
with severe ophthalmopathy [27] and in dermopathic skin [23]. The 
expression in those tissues is most likely the consequence of the 
action of interferon gamma. The recruitment of activated T lym-
phocytes to tissues involved in a manifestation of Graves' disease 
implies the potential role for interferon gamma in the pathogenesis 
of that process [17]. 
These studies offer evidence that specific protein synthesis in 
fibroblasts from different regions of the skin varies qualitatively and 
quantitatively. Moreover, response to a major class of inflammatory 
cytokine appears to depend on the site of cellular origin. These 
idiosyncrasies in phenotypic attributes of fibroblasts cannot be 
ascribed to interpersonal variations because the comparisons made 
involved multiple strains obtained from single donors. Our findings 
may be of importance to the question of why the skin of the leg is 
uniquely vulnerable to the inflammatory cascade associated with 
Graves' dermopathy. 
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